Are we nearing the end of the smartphone era?
In this episode, a16z Growth General Partner David George talks with Meta CTO Andrew “Boz” Bosworth about what comes after apps and touchscreens. From smart glasses to AR headsets, Boz shares how AI is powering a new wave of computing—one that’s ambient, agentic, and driven by human intent.
They explore what it takes to build for this future, the risks of changing interaction models, and why the next big platform shift may already be in motion.
This episode is part of our AI Revolution series, where we explore how industry leaders are leveraging generative AI to steer innovation and navigate the next major platform shift. Discover more insights and content from the AI Revolution series at a16z.com/AIRevolution.
Resources:
Find Boz on X: https://x.com/boztank
Find David on X: https://x.com/davidgeorge8
Stay Updated:
Let us know what you think: https://ratethispodcast.com/a16z
Find a16z on Twitter: https://twitter.com/a16z
Find a16z on LinkedIn: https://www.linkedin.com/company/a16z
Subscribe on your favorite podcast app: https://a16z.simplecast.com/
Follow our host: https://twitter.com/stephsmithio
Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.

-
Section 230: Everything You Need to Know — Tweets, Free Speech, Beyond
All about section 230 of the Communications Decency Act — in what Wired senior writer (and host of the Get Wired podcast) described as “one of the clearest-but-still-nuanced explainers I’ve heard – worth listening to”. …
-
Baumol’s Cost Disease, in Healthcare… and Where We Go Next
If software’s eating the world — and more specifically, bringing costs down and increasing productivity through entire industries — why have some industries, like healthcare, been so resistant? And what could the future look like…
-
Words of 2020! (and Metaphors, and Interfaces of the Year)
“In a year that left us speechless, 2020 has been filled with new words unlike any other”… so it’s unprecedented that for the first time, the Oxford English Dictionary did NOT name a word of…
-
The Machine That Made the Vaccine: Company, Platform, Innovation
In this special episode of Bio Eats World — which aired right after the FDA authorized Moderna’s mRNA vaccine for emergency use — Moderna CEO Stephane Bancel tells the story of not just the vaccine’s…
-
The PPP Omnibus: Eminent Domain, Fraud, and Fintech
This episode features two relevant but previously recorded episodes, discussing the relevance of the Paycheck Protection Program (or PPP) from the Small Business Administration and the role of government stimulus/ pandemic relief for the economy…
-
The Holy Grail of Social + Fintech
The intersection of social and finance—as well as shifting attitudes around what we share about money online—have given way to an ambitious new wave of financial products. While revealing one’s financial information was once considered…
-
On Fear and Leadership: Product to Sales CTOs & CEOs
There’s a few ontologies for describing the phases leaders — and their startups — go through, whether it’s product-sales-etc. or pioneer to settler. In any case, as companies evolve, so must the leaders — but…
-
On Food As Medicine (A Holiday Snack)
What happens if we treat food as a medicine in the healthcare system: How, where, and who (pays)? What role can technology play in increasing access, distribution, and more? General partner Julie Yoo talks with…
-
Crypto Creators: On Art Galleries to ‘Tokenized’ Collectibles
This episode features Q&As with two artists who are exploring crypto-powered auction sites and marketplaces – this is part of our ongoing series on the creator economy. The big picture is that emerging “tokenization” models,…
-
What to Know about Those Vaccines
A vaccine for COVID seems to be (almost) here… or is it? What’s hype/ what’s real beyond the headlines (and beyond the press release), when it comes to the announcement last week from Pfizer and…